ReviewFrontiers in medicine2024

New clinical insight in amyotrophic lateral sclerosis and innovative clinical development from the non-profit repurposing trial of the old drug guanabenz.

Anna Ambrosini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.